Table 5.
Luminal A2 | Luminal B3 | HER2-neu Over-expressing4 | Basal5 | |||||
---|---|---|---|---|---|---|---|---|
Relative with breast cancer | N | HR6 (95%CI) | N | HR6 (95%CI) | N | HR6 (95%CI) | N | HR6 (95%CI) |
No family history (Ref.) | 191 | 1.0 | 11 | 1.0 | 5 | 1.0 | 36 | 1.0 |
2nd degree history only | 75 | 1.23 (0.94-1.61) | 8 | 1.98 (0.79-4.94) | 9 | 4.87 (1.62-14.6) | 4 | 0.33 (0.12-0.93) |
Any 1st degree history | 125 | 1.78 (1.42-2.23) | 8 | 2.10 (0.84-5.22) | 5 | 2.91 (0.84-10.1) | 13 | 1.01 (0.53-1.90) |
Estimated using Cox Proportional Hazards models among women in the Group Health Breast Cancer Screening Program between June 1, 2001 and December 31, 2005
ER+ and/or PR+, HER2-
ER+ and/or PR+, HER2+
ER-, PR-, HER2+
ER-, PR-, HER2-
Adjusted for age at baseline (quadratic)